
Ethambutol Hydrochloride Tablets IP 200 mg: Each film-coated tablet contains Ethambutol Hydrochloride IP 200 mg.
Ethambutol Hydrochloride Tablets IP 400 mg: Each film-coated tablet contains Ethambutol Hydrochloride IP 400 mg.
Ethambutol Hydrochloride Tablets IP 800 mg: Each film-coated tablet contains Ethambutol Hydrochloride IP 800 mg.
Ethambutol Hydrochloride Tablets BP 200 mg: Each film-coated tablet contains Ethambutol Hydrochloride BP 200 mg.
Ethambutol Hydrochloride Tablets BP 400 mg: Each film-coated tablet contains Ethambutol Hydrochloride BP 400 mg.
Ethambutol Hydrochloride Tablets BP 800 mg: Each film-coated tablet contains Ethambutol Hydrochloride BP 800 mg.
Usage: Treatment of tuberculosis as part of an appropriate combination regimen.
Category: Antibiotic Drugs
Therapeutic Category: Antimycobacterial / Anti-tuberculosis
SKU: Ethambutol Tablets
Categories: Pharmaceutical Exporter India, Pharmaceutical Formulations India, WHO GMP Certified Formulations
Ethambutol Tablets is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.
For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.
Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)
Healthy Life Pharma Pvt. Ltd. manufactures Ethambutol Hydrochloride Tablets in India. Ethambutol is an antimycobacterial medicine used as part of combination regimens for tuberculosis (TB). It is not used alone to treat active TB because resistance can develop. The combination and duration of therapy depend on drug susceptibility, national TB program guidance and individual clinical circumstances.
| Parameter | Specification |
|---|---|
| Product Name | Ethambutol Hydrochloride Tablets |
| Primary Strengths | 200 mg / 400 mg / 800 mg |
| Additional Strengths | 600 mg / 1000 mg only if separately manufactured and registered |
| Standards | IP / BP according to the specific product |
| Dosage Form | Film-coated tablets |
| Therapeutic Class | Antimycobacterial / Anti-tuberculosis agent |
| Packaging | Blister, strip or bulk pack according to registration |
| Shelf Life | According to product-specific validated stability data |
Ethambutol inhibits mycobacterial arabinosyl transferases involved in cell-wall arabinogalactan biosynthesis. It is primarily bacteriostatic and is used with other effective drugs for susceptible TB. It may also be included in selected regimens for nontuberculous mycobacterial infections, such as Mycobacterium avium complex, under specialist guidance.
Drug-resistant TB or retreatment regimens should be based on susceptibility testing and current guidelines, not automatic higher-dose schedules.
Product-specific CTD/ACTD documentation, certificates of analysis and applicable regulatory certificates may be provided subject to availability and market requirements. Export packaging and shipping are arranged in line with registered storage and distribution specifications.
Who manufactures Ethambutol Tablets?
Healthy Life Pharma Pvt. Ltd., India.
Is it Myambutol?
Myambutol is a brand containing ethambutol. Equivalence to a particular reference product requires appropriate product-specific regulatory evidence.
Can it affect vision?
Yes. Optic neuropathy can affect visual acuity and colour vision. Patients should report blurred vision or colour changes immediately and receive prompt medical assessment.
Is dose adjustment needed with kidney disease?
Yes, reduced renal function can increase exposure and may require dose or interval adjustment and closer monitoring.
Ethambutol dosing is weight-based and depends on the treatment regimen, renal function, age, susceptibility results and applicable TB guidance. It must be taken with other prescribed anti-TB medicines, not as monotherapy for active TB. Prescribers should follow current national or WHO-aligned protocols and the registered product label.
Store according to the registered product label, protected from excessive heat and moisture. Keep packaging tightly closed and out of reach of children.